Much of the potential insurance upside hinges on the banking system. Groshans argued that rescheduling would encourage banks ...

Tilray Brands and Canopy Growth jumped more than 40 per cent in New York trading. A specialist fund, the Amplify Seymour ...

Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to ...

Canopy Growth ( CGC +44.69%) stock soared 17% through 12:50 p.m. ET Friday on some positive marijuana news out of the White ...

Tilray Brands ( TLRY +25.98%) stock went up like a rocket this morning, soaring 25% through 10:15 a.m. ET -- and the stock ...

Marijuana currently is classified as a Schedule I drug, which the DEA describes as a substance with no "medical use and a ...

President Donald Trump is preparing an executive order that would push federal agencies to loosen restrictions on marijuana ...

The Senate is expected to vote on dueling partisan health care proposals as an Obamacare subsidy is set to expire on 31. Meanwhile, a coalition of European leaders are expected to meet to discuss ...

The Trump administration says the tanker was involved in “illicit oil shipping”, but Venezuela accuses the US of “theft” and ...

Democratic senators are demanding more details on the drug pricing deals that Pfizer Inc., Eli Lilly & Co. and others have struck with the Trump administration in an effort to understand whether ...

Venezuela’s foreign affairs minister denounced the seizure, calling it a “blatant theft” and “an act of international piracy.

While pharmaceutical pricing has been a controversial topic for many years, a new spotlight was shone on it over the past 12 months.